Romiplostim in children with chronic immune thrombocytopenia (ITP): the French Experience

Long-term treatment with romiplostim in patients with chronic immune thrombocytopenia: safety and efficacy

(2013) David J. Kuter et al.   BRITISH JOURNAL OF HAEMATOLOGY

Leukaemic transformation with romiplostim

(2012) Kate Gardner et al.   BRITISH JOURNAL OF HAEMATOLOGY

Bleeding severity as an important outcome in childhood immune thrombocytopenia

(2012) Adolfo Flores et al.   PEDIATRIC BLOOD & CANCER

Use of Romiplostim for Primary Immune Thrombocytopenia in Children

(2012) Vicente Escudero Vilaplana et al.   PEDIATRIC HEMATOLOGY AND ONCOLOGY

Romiplostim therapy in children with unresponsive chronic immune thrombocytopenia

(2012) Galila M. Mokhtar et al.   PLATELETS

Romiplostim in children with chronic refractory ITP: randomized placebo controlled study

(2011) Mohsen Saleh Elalfy et al.   ANNALS OF HEMATOLOGY

A randomized, double-blind study of romiplostim to determine its safety and efficacy in children with immune thrombocytopenia

(2011) J. B. Bussel et al.   BLOOD

The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia

(2011) C. Neunert et al.   BLOOD

Romiplostim or Standard of Care in Patients with Immune Thrombocytopenia

(2010) David J. Kuter et al.   NEW ENGLAND JOURNAL OF MEDICINE

International consensus report on the investigation and management of primary immune thrombocytopenia

(2009) D. Provan et al.   BLOOD

Safety and efficacy of long-term treatment with romiplostim in thrombocytopenic patients with chronic ITP

(2008) J. B. Bussel et al.   BLOOD

Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group

(2008) F. Rodeghiero et al.   BLOOD